Knight Therapeutics Inc. ( KHTRF) - Stock Earnings
KHTRF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
KHTRF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 6.5 million USD | 97.0 million USD |
| 2026Q1 | 9.5 million USD | 106.7 million USD |
| 2026Q2 | -2.4 million USD | 101.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
KHTRF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.7 million USD | 247.4 million USD |
| 2024 | 3.0 million USD | 258.3 million USD |
| 2025 | -3.9 million USD | 328.0 million USD |
| 2026 Est. | — | — |
KHTRF
Price: $7.71
52 week price:
Earnings Per Share: 0.11 USD
P/E Ratio: 62.25
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 731.8 million